| POLAR CAPITAL BIOTECHNOLOGY I EUR DIS | RVI BIOTECNOLOGÍA | 81,13% | 100,40% | 101,66% | 416,14% |
| FIDELITY FUNDS-EMERGING MARKETS EX CHINA Y-ACC-EUR | RVI EMERGENTES | 81,11% | 128,13% | · | · |
| FIDELITY FUNDS-EMERGING MARKETS EX CHINA I-ACC-GBP | RVI EMERGENTES | 80,98% | 130,24% | · | · |
| FIDELITY FUNDS-EMERGING MARKETS EX CHINA Y-ACC-USD | RVI EMERGENTES | 80,98% | 129,81% | · | · |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS | RVI BIOTECNOLOGÍA | 80,85% | 100,66% | 101,46% | 419,50% |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS A-ACC-EUR (HEDGED) | RVI ASIA EX-JAPÓN SMALL/MID CAP | 80,46% | 114,51% | 54,04% | 160,90% |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 80,36% | 99,15% | 97,63% | 395,36% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 80,32% | 97,90% | 97,60% | 395,26% |
| FAST-EMERGING MARKETS FUND A-PF-ACC-EUR H | RVI EMERGENTES | 80,21% | 158,76% | 79,83% | 184,57% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I SD (CLOSE) EUR CAP | RVI EMERGENTES | 80,18% | · | · | · |
